Zai Lab Ltd (NASDAQ:ZLAB)
| 128.63 BATS BZX Real-Time Price As of Sep 17 |  0.00 / 0.00%Today’s Change | 72.76 Today|||52-Week Range 193.54 | -4.96% Year-to-Date |
Latest ZLAB News | Press Releases
| Zai Lab (ZLAB) President & COO Tao Fu Sold $1.3 million of Shares Sep 17 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 128.63 |
| Today’s open | 127.65 |
| Day’s range | 122.18 - 129.81 |
| Volume | 38,071 |
| Average volume (3 months) | 498,144 |
| Market cap | $12.2B |
Data as of 4:00pm ET, 09/17/2021
Growth & Valuation
| Earnings growth (last year) | -56.12% |
| Earnings growth (this year) | -72.17% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +277.68% |
| P/E ratio | NM |
| Price/Sales | 214.34 |
| Price/Book | 9.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NTLAIntellia Therapeutic... | -7.40 | -4.71% |
| BMRNBiomarin Pharmaceuti... | -0.46 | -0.59% |
| CRSPCRISPR Therapeutics ... | -5.27 | -4.23% |
| NBIXNeurocrine Bioscienc... | -1.58 | -1.64% |
Data as of 9:39am ET, 09/20/2021
Financials
| Next reporting date | December 1, 2021 |
| EPS forecast (this quarter) | -$1.11 |
| Annual revenue (last year) | $49.0M |
| Annual profit (last year) | -$269.4M |
| Net profit margin | -549.26% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Shanghai, Shanghai |
Forecasts
